Catherine Scholz

Catherine Scholz currently serves as Vice President and Product Team Leader at Day One Biopharmaceuticals, a position held since July 2024. Previously, Catherine held the role of Vice President of Program Leadership at Ikena Oncology from February 2023 to June 2024. Catherine also worked as Senior Vice President of Program Management at Exo Therapeutics for a brief period in 2022, where responsibilities included leading the Program Management team, strategic portfolio implementation, and supporting business development initiatives. Prior experience includes serving as Vice President of Development at H3 Biomedicine, focusing on global development strategy and execution, and Kura Oncology, where Catherine was Development Team Leader for a key oncology asset. Catherine earned a Doctor of Pharmacy and a BS in Pharmacy with Honors from Rutgers University between January 1995 and January 2001.